CSF-1R inhibition alters macrophage polarization and blocks glioma progression

Pyonteck, Stephanie M, Akkari, Leila, Schuhmacher, Alberto J, Bowman, Robert L, Sevenich, Lisa, Quail, Daniela F, Olson, Oakley C, Quick, Marsha L +12 more·2013·Nature Medicine

Cited by (1,005)

Items 301–400 of 1,005

  1. Macrophage-Derived Granulin Drives Resistance to Immune Checkpoint Inhibition in Metastatic Pancreatic Cancer
    Valeria Quaranta, Carolyn Rainer, Sebastian Rune Nielsen, Meirion Raymant, Muhammad S. Ahmed, Dannielle D. Engle, Arthur Taylor, Trish Murray, Fiona Campbell, Daniel H. Palmer et al. · 2018 · Cancer Research
  2. Multifunctional ginsenoside Rg3-based liposomes for glioma targeting therapy
    Ying Zhu, Jianming Liang, Caifang Gao, Anni Wang, Jiaxuan Xia, Chao Hong, Zhirong Zhong, Zhong Zuo, Jisu Kim, Hongwei Ren et al. · 2020 · Journal of Controlled Release
  3. Dissecting intratumoral myeloid cell plasticity by single cell RNA-seq
    Song, Qianqian, Hawkins, Gregory A., Wudel, Leonard, Chou, Ping‐Chieh, Forbes, Elizabeth, Pullikuth, Ashok K., Liu, Liang, Jin, Guangxu, Craddock, Lou, Topaloglu, Umit et al. · 2019 · Cancer Medicine
  4. Combinations with Allosteric SHP2 Inhibitor TNO155 to Block Receptor Tyrosine Kinase Signaling
    Liu, Chen, Lu, Hengyu, Wang, Hongyun, Loo, Alice, Zhang, Xiamei, Yang, Guizhi, Kowal, Colleen, Delach, Scott, Wang, Ye, Goldoni, Silvia et al. · 2021 · Clinical Cancer Research
  5. Dectin-1 Activation by a Natural Product β-Glucan Converts Immunosuppressive Macrophages into an M1-like Phenotype
    Min Liu, Fengling Luo, Chuanlin Ding, Sabrin Albeituni, Xiaoling Hu, Yunfeng Ma, Yihua Cai, Lacey R. McNally, Mary Ann Sanders, Dharamvir Jain et al. · 2015 · The Journal of Immunology
  6. The roles of microglia macrophages in tumor progression of brain cancer and metastatic disease
    Shih-Ying Wu · 2017 · Frontiers in bioscience
  7. HDAC inhibition potentiates anti-tumor activity of macrophages and enhances anti-PD-L1-mediated tumor suppression
    Xiaolei Li, Xiao Su, Rui Liu, Yongsha Pan, Jiankai Fang, Lijuan Cao, Chao Feng, Qianwen Shang, Yongjing Chen, Changshun Shao et al. · 2021 · Oncogene
  8. Transcriptome Analysis of Individual Stromal Cell Populations Identifies Stroma-Tumor Crosstalk in Mouse Lung Cancer Model
    Hyejin Choi, Jianting Sheng, Dingcheng Gao, Fuhai Li, Anna Durrans, Seongho Ryu, Sharrell B. Lee, Navneet Narula, Shahin Rafii, Olivier Elemento et al. · 2015 · Cell Reports
  9. Metformin prevents cancer metastasis by inhibiting M2-like polarization of tumor associated macrophages
    Ling Ding, Guikai Liang, Zhangting Yao, Jieqiong Zhang, Ruiyang Liu, Huihui Chen, Yulu Zhou, Honghai Wu, Bo Yang, Qiaojun He · 2015 · Oncotarget
  10. Myeloid-targeted immunotherapies act in synergy to induce inflammation and antitumor immunity
    Curtis J. Perry, A. Muñoz-Rojas, K. Meeth, Laura N. Kellman, R. Amezquita, D. Thakral, Victor Y. Du, Jake X Wang, W. Damsky, Alexandra Kuhlmann et al. · 2018 · Journal of Experimental Medicine
  11. Inhibition of Rspo-Lgr4 Facilitates Checkpoint Blockade Therapy by Switching Macrophage Polarization
    Binghe Tan, Xiujuan Shi, Jie Zhang, Juliang Qin, Na Zhang, Hua Ren, Min Qian, Stefan K. Siwko, Kendra S. Carmon, Qingyun Liu et al. · 2018 · Cancer Research
  12. Metabolism drives macrophage heterogeneity in the tumor microenvironment
    Shasha Li, Jiali Yu, Amanda K. Huber, Ilona Kryczek, Zhuwen Wang, Long Jiang, Xiong Li, Wan Du, Gaopeng Li, Shuang Wei et al. · 2022 · Cell Reports
  13. Combination of CD40 Agonism and CSF-1R Blockade Reconditions Tumor-Associated Macrophages and Drives Potent Antitumor Immunity
    Karla R. Wiehagen, N. Girgis, Douglas H. Yamada, Andressa A. Smith, S. Chan, I. Grewal, M. Quigley, R. Verona · 2017 · Cancer immunology research
  14. Monocyte-derived macrophages promote breast cancer bone metastasis outgrowth
    Ruo-Yu Ma, Hui Zhang, Xue-Feng Li, Cheng-Bin Zhang, Cigdem Selli, G. Tagliavini, Alyson D. Lam, S. Prost, A. Sims, Hai-Yan Hu et al. · 2020 · Journal of Experimental Medicine
  15. Dissecting the immunosuppressive tumor microenvironments in Glioblastoma-on-a-Chip for optimized PD-1 immunotherapy
    Xin Cui, Chao Ma, Varshini Vasudevaraja, Jonathan Serrano, Jie Tong, Yansong Peng, Michael DeLorenzo, Guomiao Shen, Joshua D. Frenster, Renee‐Tyler T. Morales et al. · 2020 · eLife
  16. Distribution and prognostic impact of microglia/macrophage subpopulations in gliomas
    Pia Susann Zeiner, Corinna Preuße, Anna Golebiewska, Jenny Zinke, Ane Iriondo, Arnaud Muller, Tony Kaoma, Katharina Filipski, Monika Müller-Eschner, Simon Bernatz et al. · 2018 · Brain Pathology
  17. Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas
    Katrin Aslan, Verena Turco, Jens Blobner, Jana K. Sonner, Anna Rita Liuzzi, Nicolás Gonzalo Núñez, Donatella De Feo, Philipp Kickingereder, Manuel Dominik Fischer, Ed Green et al. · 2020 · Nature Communications
  18. Dual Role of WISP1 in maintaining glioma stem cells and tumor-supportive macrophages in glioblastoma
    Weiwei Tao, Cheng‐Wei Chu, Wenchao Zhou, Zhi Huang, Kui Zhai, Xiaoguang Fang, Qian Huang, Aili Zhang, Xiuxing Wang, Xingjiang Yu et al. · 2020 · Nature Communications
  19. FGF2 alters macrophage polarization, tumour immunity and growth and can be targeted during radiotherapy
    Jae Hong Im, Jon N. Buzzelli, Keaton Ian Jones, Fanny Franchini, Alex Nicolas Gordon-Weeks, Boštjan Markelc, Jianzhou Chen, Jin Kim, Yunhong Cao, Ruth J. Muschel · 2020 · Nature Communications
  20. Targeting tumor-associated macrophages as an antitumor strategy
    Nan Cheng, Xuexia Bai, Yuxin Shu, Owais Ahmad, Pingping Shen · 2020 · Biochemical Pharmacology
  21. Re-Education of Macrophages as a Therapeutic Strategy in Cancer
    Kowal, Joanna, Kornete, Mara, Joyce, Johanna A · 2019 · Immunotherapy
  22. Macropinocytosis of Nab-paclitaxel Drives Macrophage Activation in Pancreatic Cancer
    Jane E. Cullis, Despina Siolas, Antonina Avanzi, Sugata Barui, Anirban Maitra, Dafna Bar‐Sagi · 2017 · Cancer Immunology Research
  23. Role of the nervous system in cancers: a review
    Huan Wang, Qiming Zheng, Zeyi Lu, Liya Wang, Lifeng Ding, Liqun Xia, Hao Zhang, Mingchao Wang, Yi-Cheng Chen, Gonghui Li · 2021 · Cell Death Discovery
  24. Targeting vascular and leukocyte communication in angiogenesis, inflammation and fibrosis
    Kreuger, Johan, Phillipson, Mia · 2016 · Nature Reviews Drug Discovery
  25. Metastasis review: from bench to bedside
    Ali Mohammad Alizadeh, Sadaf Shiri, Sadaf Farsinejad · 2014 · Tumor Biology
  26. The CD14+HLA-DRlo/neg Monocyte: An Immunosuppressive Phenotype That Restrains Responses to Cancer Immunotherapy
    April E. Mengos, Dennis A. Gastineau, Michael P. Gustafson · 2019 · Frontiers in Immunology
  27. Modulating inflammation for cancer therapy
    Birgit Ritter, Florian R. Greten · 2019 · The Journal of Experimental Medicine
  28. High-throughput phenotypic screen and transcriptional analysis identify new compounds and targets for macrophage reprogramming
    Guangan Hu, Yang Su, Byong Ha Kang, Zhongqi Fan, Ting Dong, Douglas R. Brown, Jaime H. Cheah, Karl Dane Wittrup, Jianzhu Chen · 2021 · Nature Communications
  29. Intertwined regulation of angiogenesis and immunity by myeloid cells
    Lee B. Rivera, Gabriele Bergers · 2015 · Trends in Immunology
  30. TLR-3 Stimulation Skews M2 Macrophages to M1 Through IFN-αβ Signaling and Restricts Tumor Progression
    Aurobind Vidyarthi, Nargis Khan, Tapan Agnihotri, Shikha Negi, Deepjyoti Kumar Das, Mohammad Aqdas, Deepyan Chatterjee, Oscar R. Colegio, Manoj Kumar Tewari, Javed Naim Agrewala · 2018 · Frontiers in Immunology
  31. Immunotherapy for Malignant Glioma: Current Status and Future Directions
    Hongxiang Wang, Tao Xu, Qilin Huang, Weilin Jin, Juxiang Chen · 2020 · Trends in Pharmacological Sciences
  32. Lactate dehydrogenase A regulates tumor-macrophage symbiosis to promote glioblastoma progression
    Fatima Khan, Yiyun Lin, Heba A. Ali, Lizhi Pang, Madeline Dunterman, Wen-Hao Hsu, Katie Frenis, R. Grant Rowe, Derek Alan Wainwright, Kathleen McCortney et al. · 2024 · Nature Communications
  33. Tumor-Associated Macrophages Derived from Circulating Inflammatory Monocytes Degrade Collagen through Cellular Uptake
    Daniel Hargbøll Madsen, Henrik J. Jürgensen, Majken Storm Siersbæk, Dorota Ewa Kuczek, Loretta Grey Cloud, Shihui Liu, Niels Behrendt, Lars Grøntved, Roberto Weigert, Thomas Henrik Bugge · 2017 · Cell Reports
  34. Monocyte Regulation in Homeostasis and Malignancy
    Amy Robinson, Claudia Z. Han, Christopher K. Glass, Jeffrey W. Pollard · 2021 · Trends in Immunology
  35. Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
    Antonino Glaviano, Hannah Lau, Lukas M. Carter, E. Hui Clarissa Lee, Hiu Yan Lam, Elena Okina, Donavan Jia Jie Tan, Wency Tan, Hui Li Ang, Daniela Carbone et al. · 2025 · Journal of Hematology & Oncology
  36. Mechanisms that drive inflammatory tumor microenvironment, tumor heterogeneity, and metastatic progression
    Howard Hua Yang, P. Charles Lin · 2017 · Seminars in Cancer Biology
  37. Microglia promote glioblastoma via mTOR‐mediated immunosuppression of the tumour microenvironment
    Anaelle A Dumas, Nicola Pomella, Gabriel Rosser, Loredana Guglielmi, Claire Vinel, Thomas O Millner, Jeremy H. Rees, Natasha Aley, Denise Sheer, Jun Wei et al. · 2020 · The EMBO Journal
  38. Lurbinectedin reduces tumour-associated macrophages and the inflammatory tumour microenvironment in preclinical models
    Cristina Belgiovine, Ezia Bello, Manuela Liguori, Ilaria Craparotta, Laura Mannarino, Lara Paracchini, Luca Beltrame, Sergio Marchini, Carlos María Galmarini, Alberto Mantovani et al. · 2017 · British Journal of Cancer
  39. The Microenvironment of Lung Cancer and Therapeutic Implications
    Vivek Mittal, Tina El Rayes, Navneet Narula, Timothy E. McGraw, Nasser Khaled Altorki, Mary Helen Barcellos‐Hoff · 2015 · Advances in experimental medicine and biology
  40. Synergistic immunotherapy of glioblastoma by dual targeting of IL-6 and CD40
    Fan Yang, Zhenqiang He, Hao Duan, Duo Zhang, Juehui Li, Huijuan Yang, Jay F. Dorsey, Wei Zou, S. Ali Nabavizadeh, Stephen Joseph Bagley et al. · 2021 · Nature Communications
  41. Turn Back the TIMe: Targeting Tumor Infiltrating Myeloid Cells to Revert Cancer Progression
    Robin Maximilian Awad, Yannick De Vlaeminck, Johannes Maebe, Cleo Goyvaerts, Karine Breckpot · 2018 · Frontiers in Immunology
  42. Monocytes Differentiate to Immune Suppressive Precursors of Metastasis-Associated Macrophages in Mouse Models of Metastatic Breast Cancer
    Takanori Kitamura, Dahlia Doughty-Shenton, Luca Cassetta, Stamatina Fragkogianni, Demi Brownlie, Yu Kato, Neil O. Carragher, Jeffrey W. Pollard · 2018 · Frontiers in Immunology
  43. Harnessing anti‐tumor and tumor‐tropism functions of macrophages via nanotechnology for tumor immunotherapy
    Yanhui Zheng, Yaobao Han, Qiao Sun, Zhen Li · 2022 · Exploration
  44. MDM2 inhibitor APG-115 synergizes with PD-1 blockade through enhancing antitumor immunity in the tumor microenvironment
    Fang, Douglas D., Tang, Qiuqiong, Kong, Yanhui, Wang, Qixin, Gu, Jiaxing, Fang, Xu, Zou, Peng, Rong, Tao, Wang, Jingwen, Yang, Dajun et al. · 2019 · Journal for ImmunoTherapy of Cancer
  45. Tissue-resident versus monocyte-derived macrophages in the tumor microenvironment
    Qods Lahmar, Jiri Keirsse, Damya Laoui, Kiavash Movahedi, Eva Van Overmeire, Jo A. Van Ginderachter · 2015 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  46. Colony stimulating factor-1 receptor signaling networks inhibit mouse macrophage inflammatory responses by induction of microRNA-21
    Cristina I. Caescu, Xingyi Guo, Lydia Tesfa, Tushar Damodar Bhagat, Amit K. Verma, Deyou Zheng, E. Richard Stanley · 2015 · Blood
  47. Cancer Immunotherapy: Beyond Checkpoint Blockade
    Michael Lawrence Dougan, Glenn Dranoff, Stephanie K. Dougan · 2018 · Annual Review of Cancer Biology
  48. Perspective of mesenchymal transformation in glioblastoma
    Yona Kim, Frederick S. Varn, Sung‐Hye Park, Byung Woo Yoon, Hye Ran Park, Charles Lee, Roel G.W. Verhaak, Sun Ha Paek · 2021 · Acta Neuropathologica Communications
  49. Macrophage‐Mediated Tumor Cell Phagocytosis: Opportunity for Nanomedicine Intervention
    Xuefei Zhou, Xiangrui Liu, Leaf Huang · 2020 · Advanced Functional Materials
  50. Targeting myeloid-derived suppressor cells with colony stimulating factor-1 receptor blockade can reverse immune resistance to immunotherapy in indoleamine 2,3-dioxygenase-expressing tumors
    Rikke Holmgaard, Dmitriy Zamarin, Alexander M. Lesokhin, Taha Merghoub, Jedd D. Wolchok · 2016 · EBioMedicine
  51. Tumor-Associated Macrophages Suppress the Cytotoxic Activity of Antimitotic Agents
    Oakley C. Olson, Hyun-Jung Kim, Daniela F. Quail, Emily A. Foley, Johanna A. Joyce · 2017 · Cell Reports
  52. Dual Role of Macrophage in Tumor Immunity
    Ryota Tamura, Toshihide Tanaka, Yohei Yamamoto, Yasuharu Akasaki, Hikaru Sasaki · 2018 · Immunotherapy
  53. Myeloid Cells in Glioblastoma Microenvironment
    Alessandra De Leo, Alessio Ugolini, Filippo Veglia · 2020 · Cells
  54. C–C Chemokine Ligand 2 (CCL2) Recruits Macrophage-Membrane-Camouflaged Hollow Bismuth Selenide Nanoparticles To Facilitate Photothermal Sensitivity and Inhibit Lung Metastasis of Breast Cancer
    Hongjuan Zhao, Li Li, Junli Zhang, Cuixia Zheng, Kaili Ding, Huifang Xiao, Lei Wang, Zhenzhong Zhang · 2018 · ACS Applied Materials & Interfaces
  55. Quantitative Imaging of Tumor-Associated Macrophages and Their Response to Therapy Using 64Cu-Labeled Macrin
    Hye-Yeong Kim, Ran Li, Thomas S.C. Ng, Gabriel Courties, Christopher B. Rodell, Mark Prytyskach, Rainer H. Köhler, Mikaël J. Pittet, Matthias Nahrendorf, Ralph Weissleder et al. · 2018 · ACS Nano
  56. New Mechanisms of Tumor-Associated Macrophages on Promoting Tumor Progression: Recent Research Advances and Potential Targets for Tumor Immunotherapy
    Qiujun Guo, Zhichao Jin, Yuan Yuan, Rui Liu, Tao Xu, Huamin Wei, Xinyao Xu, Shulin He, Shuntai Chen, Zhan Shi et al. · 2016 · Journal of Immunology Research
  57. Depletion of Tumor-Associated Macrophages with a CSF-1R Kinase Inhibitor Enhances Antitumor Immunity and Survival Induced by DC Immunotherapy
    Floris F. Dammeijer, Lysanne A. Lievense, Margaretha E.H. Kaijen-Lambers, Menno van Nimwegen, Koen Bezemer, Joost P. Hegmans, Thorbald van Hall, Rudi W. Hendriks, Joachim G.J.V. Aerts · 2017 · Cancer Immunology Research
  58. Immune regulation of metastasis: mechanistic insights and therapeutic opportunities
    Olga S. Blomberg, Lorenzo Spagnuolo, Karin E. de Visser · 2018 · Disease Models & Mechanisms
  59. Macrophage M2 polarization induced by exosomes from adipose-derived stem cells contributes to the exosomal proangiogenic effect on mouse ischemic hindlimb
    Dihan Zhu, Takerra K. Johnson, Yang Wang, Miracle Thomas, Ky Huynh, Qinglin Yang, Vincent Craig Bond, Y. Eugene Chen, Dong Liu · 2020 · Stem Cell Research & Therapy
  60. ARS2/MAGL signaling in glioblastoma stem cells promotes self-renewal and M2-like polarization of tumor-associated macrophages
    Jinlong Yin, Sung Soo Kim, Eunji Choi, Young Taek Oh, Weiwei Lin, Tae Hoon Kim, Jason K. Sa, Jun Hee Hong, Saewhan Park, Hyung Joon Kwon et al. · 2020 · Nature Communications
  61. Cancer cell autophagy, reprogrammed macrophages, and remodeled vasculature in glioblastoma triggers tumor immunity
    Agnieszka Chryplewicz, Julie Scotton, Mélanie Tichet, Anoek Zomer, Ksenya Shchors, Johanna A. Joyce, Krisztián Homicskó, Douglas Hanahan · 2022 · Cancer Cell
  62. CNS macrophages and peripheral myeloid cells in brain tumours
    Rainer Glaß, Michael Synowitz · 2014 · Acta Neuropathologica
  63. Tumor-Associated Microglia and Macrophages in the Glioblastoma Microenvironment and Their Implications for Therapy
    Rikke Sick Andersen, Atul Anand, Dylan Scott Lykke Harwood, Bjarne Winther Kristensen · 2021 · Cancers
  64. Type I Interferon Receptor Signaling of Neurons and Astrocytes Regulates Microglia Activation during Viral Encephalitis
    Chhatbar, Chintan, Detje, Claudia N., Grabski, Elena, Borst, Katharina, Spanier, Julia, Ghita, Luca, Elliott, David A., Jordão, Marta Joana Costa, Mueller, Nora, Sutton, James et al. · 2018 · Cell Reports
  65. The role of inflammatory cytokines and tumor associated macrophages (TAMs) in microenvironment of pancreatic cancer
    Saeed Farajzadeh Valilou, Mahsa Keshavarz‐Fathi, Nicola Silvestris, Antonella Argentiero, Nima Rezaei · 2018 · Cytokine & Growth Factor Reviews
  66. Interrogating glioma-M2 macrophage interactions identifies Gal-9/Tim-3 as a viable target against PTEN -null glioblastoma
    Xiangrong Ni, Wei-Chi Wu, Xiaoqiang Sun, Jun-Xiao Ma, Zhihui Yü, Xinwei He, Jinyu Cheng, Pengfei Xu, Haoxian Liu, Tengze Shang et al. · 2022 · Science Advances
  67. Compensation between CSF1R+ macrophages and Foxp3+ Treg cells drives resistance to tumor immunotherapy
    Dávid Győri, Ee Lyn Lim, Francis M. Grant, Dominik Spensberger, Rahul Roychoudhuri, Stephen Joseph Shuttleworth, Klaus Okkenhaug, Len Stephens, Phillip T. Hawkins · 2018 · JCI Insight
  68. Context-Dependent Glioblastoma–Macrophage/Microglia Symbiosis and Associated Mechanisms
    Wenjing Xuan, Maciej S. Lesniak, Charles David James, Amy B. Heimberger, Peiwen Chen · 2021 · Trends in Immunology
  69. Immune-mediated mechanisms influencing the efficacy of anticancer therapies
    Seth B. Coffelt, Karin E. de Visser · 2015 · Trends in Immunology
  70. Targeting Suppressive Myeloid Cells Potentiates Checkpoint Inhibitors to Control Spontaneous Neuroblastoma
    Yumeng Mao, Nina Eißler, Katarina Le Blanc, John Inge Johnsen, Per Kogner, Rolf W. Kiessling · 2016 · Clinical Cancer Research
  71. Hypoxia-induced ZEB1 promotes cervical cancer progression via CCL8-dependent tumour-associated macrophage recruitment
    Xiao-Jing Chen, Yuan-Run Deng, Zi‐Ci Wang, Wen-Fei Wei, Chen-Fei Zhou, Yanmei Zhang, Rui-Ming Yan, Luo-Jiao Liang, Mei Zhong, Liang Li et al. · 2019 · Cell Death and Disease
  72. Metabolic Reprogramming via ACOD1 depletion enhances function of human induced pluripotent stem cell-derived CAR-macrophages in solid tumors
    Xudong Wang, Siyu Su, Yuqing Zhu, Xiaolong Cheng, Chen Cheng, Leilei Chen, Anhua Lei, Li Zhang, Yuyan Xu, Dan Ye et al. · 2023 · Nature Communications
  73. Brain macrophage development, diversity and dysregulation in health and disease
    Silvin, Aymeric, Qian, Jiawen, Ginhoux, Florent · 2023 · Cellular & Molecular Immunology
  74. Peptide-guided resiquimod-loaded lignin nanoparticles convert tumor-associated macrophages from M2 to M1 phenotype for enhanced chemotherapy
    Patrícia Figueiredo, Anni Lepland, Pablo Scodeller, Flavia Fontana, Giulia Torrieri, Mattia Tiboni, Mohammad‐Ali Shahbazi, Luca Casettari, Mauri A. Kostiainen, Jouni J. Hirvonen et al. · 2020 · Acta Biomaterialia
  75. Nanoparticles That Reshape the Tumor Milieu Create a Therapeutic Window for Effective T-cell Therapy in Solid Malignancies
    Fan Zhang, Sirkka B. Stephan, Chibawanye Ene, Tyrel T. Smith, Eric C. Holland, Matthias T. Stephan · 2018 · Cancer Research
  76. Brain cancer stem cells: resilience through adaptive plasticity and hierarchical heterogeneity
    Ryan C. Gimple, Kailin Yang, Matthew E. Halbert, Sameer Agnihotri, Jeremy N. Rich · 2022 · Nature reviews. Cancer
  77. Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy
    Yi Wang, Kai Conrad Cecil Johnson, Margaret Elena Gatti-Mays, Zihai Li · 2022 · Journal of Hematology & Oncology
  78. Molecular Pathways: Deciphering Mechanisms of Resistance to Macrophage-Targeted Therapies
    Daniela F. Quail, Johanna A. Joyce · 2016 · Clinical Cancer Research
  79. Versatile Nano‐PROTAC‐Induced Epigenetic Reader Degradation for Efficient Lung Cancer Therapy
    Huan‐Tian Zhang, Rui Peng, Sheng Chen, Ao Shen, Lixin Zhao, Wang Tang, Xiao‐He Wang, Zhen‐Yan Li, Zhengang Zha, Mengmeng Yi et al. · 2022 · Advanced Science
  80. Balancing the innate immune system in tumor development
    C. Hagerling, A. Casbon, Z. Werb · 2014 · Trends in Cell Biology
  81. Neutrophils in Gliomas
    Matteo Massara, Pasquale Persico, Ornella Bonavita, Valeria Mollica Poeta, Massimo Locati, Matteo Simonelli, Raffaella Bonecchi · 2017 · Frontiers in Immunology
  82. Depletion of CLL-associated patrolling monocytes and macrophages controls disease development and repairs immune dysfunction in vivo
    Bola S. Hanna, Fabienne McClanahan, Haniyeh Yazdanparast, Nadja Zaborsky, Verena Kalter, Philipp M Rößner, Axel Benner, C Dürr, Alexander Egle, John G. Gribben et al. · 2015 · Leukemia
  83. Predominance of M2 macrophages in gliomas leads to the suppression of local and systemic immunity
    Aurobind Vidyarthi, Tapan Agnihotri, Nargis Khan, Sanpreet Singh, Manoj Kumar Tewari, Bishan Radotra, Deepyan Chatterjee, Javed Naim Agrewala · 2019 · Cancer Immunology Immunotherapy
  84. Predicting prognosis and therapeutic response from interactions between lymphocytes and tumor cells
    David Alan Quigley, Vessela Nedelcheva Kristensen · 2015 · Molecular Oncology
  85. Immune Checkpoint Targeted Therapy in Glioma: Status and Hopes
    Yangzhi Qi, Baohui Liu, Qian Sun, Xiaoxing Xiong, Qianxue Chen · 2020 · Frontiers in Immunology
  86. The roles of microglia in viral encephalitis: from sensome to therapeutic targeting
    Chintan Chhatbar, Marco Prinz · 2021 · Cellular and Molecular Immunology
  87. Modulation of foreign body reaction and macrophage phenotypes concerning microenvironment
    Chu, Chenyu, Liu, Li, Rung, Shengan, Wang, Yuanjing, Ma, Yuxing, Hu, Chen, Zhao, Xiwen, Man, Yi, Qu, Yili · 2020 · Journal of Biomedical Materials Research Part A
  88. Brain region-specific enhancement of remyelination and prevention of demyelination by the CSF1R kinase inhibitor BLZ945
    Beckmann, Nicolau, Giorgetti, Elisa, Neuhaus, Anna, Zurbruegg, Stefan, Accart, Nathalie, Smith, Paul, Perdoux, Julien, Perrot, Ludovic, Nash, Mark, Desrayaud, Sandrine et al. · 2018 · Acta Neuropathologica Communications
  89. Chimeric antigen receptor-modified T cells for the treatment of solid tumors: Defining the challenges and next steps
    Gregory Lawrence Beatty, Mark H. O’Hara · 2016 · Pharmacology & Therapeutics
  90. IL-10 secreted by M2 macrophage promoted tumorigenesis through interaction with JAK2 in glioma
    Ling Qi, Hongquan Yu, Yu Zhang, Donghai Zhao, Peng Lv, Yue Zhong, Ye Xu · 2016 · Oncotarget
  91. Targeting tumor associated macrophages: The new challenge for nanomedicine
    Fernando Torres Andón, Elisabeth Digifico, Akihiro Maeda, Marco Erreni, Alberto Mantovani, Marı́a José Alonso, Paola Allavena · 2017 · Seminars in Immunology
  92. The macrophage odorant receptor Olfr78 mediates the lactate-induced M2 phenotype of tumor-associated macrophages
    Sri Murugan Poongkavithai Vadevoo, Gowri Rangaswamy Gunassekaran, ChaeEun Lee, NaHye Lee, Jiyoun Lee, Sehyun Chae, Jae‐Yong Park, JaeHyung Koo, Byung-Heon Lee · 2021 · Proceedings of the National Academy of Sciences
  93. Multispectral imaging of formalin-fixed tissue predicts ability to generate tumor-infiltrating lymphocytes from melanoma
    Zipei Feng, Sachin Puri, Tarsem Lal Moudgil, William J. Wood, Clifford C. Hoyt, Chichung Wang, Walter John Urba, Brendan D. Curti, Carlo Bruno Bifulco, Bernard A. Fox · 2015 · Journal for ImmunoTherapy of Cancer
  94. Tumor-associated microglia and macrophages in glioblastoma: From basic insights to therapeutic opportunities
    Guoqing Wang, Kunhong Zhong, Zeng Wang, Zongliang Zhang, Xin Tang, Aiping Tong, Liangxue Zhou · 2022 · Frontiers in Immunology
  95. Development of individualized anti-metastasis strategies by engineering nanomedicines
    Qianjun He, Shengrong Guo, Zhiyong Qian, Xiaoyuan Shawn Chen · 2015 · Chemical Society Reviews
  96. Targeting myeloid cells in the tumor sustaining microenvironment
    Jonathan Schupp, Franziska K. Krebs, Niklas Zimmer, Emily R. Trzeciak, Detlef Schuppan, Andrea Tuettenberg · 2017 · Cellular Immunology
  97. Chitinase-3-like 1 protein complexes modulate macrophage-mediated immune suppression in glioblastoma
    Apeng Chen, Yinan Jiang, Zhengwei Li, Lingxiang Wu, Ulises Santiago, Han Zou, Chunhui Cai, Vaibhav Sharma, Yongchang Guan, Lauren H. McCarl et al. · 2021 · Journal of Clinical Investigation
  98. TGFBI secreted by tumor-associated macrophages promotes glioblastoma stem cell-driven tumor growth via integrin αvβ5-Src-Stat3 signaling
    Peng Peng, Hongtao Zhu, Dan Liu, Zirong Chen, Xiaolin Zhang, Zhongyin Guo, Minhai Dong, Lijun Wan, Po Zhang, Guohao Liu et al. · 2022 · Theranostics
  99. The Promotion of Breast Cancer Metastasis Caused by Inhibition of CSF-1R/CSF-1 Signaling Is Blocked by Targeting the G-CSF Receptor
    Agnieszka Swierczak, Andrew D. Cook, Jason C. Lenzo, Christina M. Restall, Judy P. Doherty, Robin L. Anderson, John A. Hamilton · 2014 · Cancer Immunology Research
  100. Compensatory CSF2-driven macrophage activation promotes adaptive resistance to CSF1R inhibition in breast-to-brain metastasis
    Florian Klemm, Aylin Möckl, Anna Salamero‐Boix, Tijna Alekseeva, Alexander Schäffer, Michael Schulz, Katja Niesel, Roeltje R. Maas, Marie Groth, Benelita T. Elie et al. · 2021 · Nature Cancer